Amedisys Inc ( (AMED) ) has released its Q3 earnings. Here is a breakdown of the information Amedisys Inc presented to its investors. Amedisys, ...

Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and nine-month periods ended September 30, 2024. Three-Month Periods ...

Rose Center for the Arts serves five East Tennessee counties as a Designated Agency of the Tennessee Arts Commission, ...

Home health company Amedisys, based in Louisiana and Nashville, fell short of estimates in its third quarter earnings report.

Amedisys (AMED) delivered earnings and revenue surprises of -12.28% and 0.08%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Non-Medicare and high-acuity care revenue continue to grow substantially at Amedisys Inc. (Nasdaq: AMED). While the company waits to become a part of UnitedHealth Group (NYSE: UNH) – in a $3.3 billion ...

The results fell short of Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for earnings of $1.14 per share.

BATON ROUGE, La., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and nine-month periods ended September 30, 2024. Net service ...

Participants should ask to join "TEAM, Inc. Third Quarter 2024 Conference Call.” This call will also be webcast on TEAM's website at An audio replay will be available on the Company's website ...

Donald Trump will take over the presidency again in January. There will be many implications for home-based care providers, ...

The new administration is likely to pull back on Biden-era measures affecting health insurers, drug prices and public-health ...